Assembly Biosciences, Inc. (ASMB) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 6 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for ASMB is $40.00, representing a +35.9% upside from the current price of $29.44. Price targets range from a low of $40.00 to a high of $40.00.
